Work

Abstract 94: Randomized, Double-blind, Placebo-controlled Phase 1 Study Of Vwf-binding Aptamer, Bb-031: Safety, Tolerability, Pharmacokinetic And Pharmacodynamic Activity In Healthy Volunteers

Year: 2023

Type: conference-abstract

Source: Stroke

DOI: 10.1161/str.54.suppl_1.94

Authors: Shahid M Nimjee, Debra Wheeler, Stacy Nelson, Richard J Shea, Taegen Sullivan, Christina Mayer, Leo Pavliv, Juliana M Layzer, Jason Lickliter, Bruce Sullenger, Bruce Campbell, Richard C Becker

Institutions: The Ohio State University, Cumberland Pharmaceuticals (United States), Regado Biosciences (United States), Duke University, Duke Medical Center, The Royal Melbourne Hospital, University of Cincinnati

Language: English

Topic: Platelet Disorders and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4319009152

Cites:

Cited by: 3

Related to: 10